Lloyd Mitchell Segal, Director at Valeant Pharmaceuticals International, Inc. (VRX), bought 3,190 shares at $86.44 ($268K) on 2013-06-11, disclosed to the SEC on 2013-06-13.
Open-market purchase of $268k VRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.44 | 100 | $9K | 3.2% |
| 2 | $86.45 | 200 | $17K | 6.4% |
| 3 | $86.48 | 90 | $8K | 2.9% |
| 4 | $86.73 | 300 | $26K | 9.7% |
| 5 | $83.50 | 2,500 | $209K | 77.8% |
| Total | $84.16 avg | 3,190 |
| $268K |
| 100% |
| Filing → |
| RPTX | SELL | 2024-03-27 | $37K | — | Filing → |
| RPTX | SELL | 2021-06-30 | $110K | — | Filing → |
| RPTX | SELL | 2021-06-10 | $55K | — | Filing → |